Updated Date: Wed, 20 Mar 2024 00:00:00 EDT
SARS-CoV-2 will eventually become resistant to the only effective oral treatment. The world needs another, say researchers.
The self-replicating mRNA molecule could be used in cancer and potentially a broad range of other diseases
Set to open in 2032, the RUEDI facility is funded by the UKRI’s recent infrastructure fund worth £388m
Healthcare agencies can submit their entries free of charge with a deadline of 30 April
Researchers have found that approved drugs that were originally shown to normalize blood vessels surrounding tumors (to improve […]
An enzymatic cocktail can kill a variety of mycobacterial species of bacteria, including those that cause tuberculosis.
Researchers have discovered a safer and more efficient technique for testing new drugs while they are in development.
Researchers are enhancing immunotherapy effects against malignant tumors by developing and validating patent-ending poly (lactic-co-glycolic acid), or PLGA, […]
Researchers say they have discovered that the protein puromycin-sensitive aminopeptidase (NPEPPS) plays a role in regulating response to […]